Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Acquisition (Tables)

v3.22.2
Acquisition (Tables)
12 Months Ended
Dec. 31, 2021
Acquisition [Abstract]  
Schedule of purchase price to assets acquired and liabilities
Cash and cash equivalents   $ 811,773  
Prepaid expenses and other current assets     1,977  
Balance with the Company (*)     50,000  
Investment in the Company’s shares (**)     122,482  
CLA provided to the Company (*)     167,188  
Liability to Israel National Technological Innovation Authority     (1,006,605 )
Accrued expenses and other current liabilities     (123 )
Goodwill (***)     265,089  
Total purchase price   $ 411,781